PHA-680632 ezolid with only minor body weight

with only minor body weight changes

and this increase is significantly attenuated by Pirfenidone administration on day 28 after BLM treatment (P=0

TRX-0237 dihydrobromide

is a Th2 cytokine inhibitor which is used as an antiallergic drug

PHA-680632 ezolid with only minor body weightPHA 680632 is a is potent inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 27 nM, 135 nM and 120 nM, respectively. PHA 680632 is also the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic. PHA 680632 is active on a wide range of cancer cell lines and shows significant tumor growth inhibition in different animal tumor models at well tolerated doses. Product